Showing results (41-50 of 97) with videos related to
Sort By:
Pageof 10
Transplant Immunology|October 2, 2014
Anti-B cell therapy with rituximab as induction therapy in renal transplantationI Joosten, M C Baas, E G Kamburova, et al.Sarcoma|June 4, 2008
Hyperthermic Isolated Limb Perfusion with TNF alpha and Cisplatin in the Treatment of Osteosarcoma of the Extremities: A Feasibility Study in Healthy DogsR J Van Ginkel, C L Van Berlo, P C Baas, et al.Clinical Pharmacokinetics|November 7, 2024
Drug-Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for CliniciansDavid M Burger, Laura Nijboer, Mira Ghobreyal, et al.Plos One|November 14, 2014
Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapyElena G Kamburova, Hans J P M Koenen, Martijn W F van den Hoogen, et al.Transplantation|February 13, 2015
Cytokine Release After Treatment With Rituximab in Renal Transplant RecipientsElena G Kamburova, Martijn W F van den Hoogen, Hans J P M Koenen, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2014
Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptanceMarije C Baas, Chantal Kuhn, Fabrice Valette, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2009
Mumps: not an innocent bystander in solid organ transplantationM C Baas, K A M I van Donselaar, S Florquin, et al.Thrombosis Research|August 3, 2013
Treatment with everolimus is associated with a procoagulant stateMarije C Baas, Victor E A Gerdes, Ineke J M Ten Berge, et al.Psycho-Oncology|October 23, 2018
Shared decision making in oncology: A model based on patients', health care professionals', and researchers' viewsHanna Bomhof-Roordink, Maarten J Fischer, Nanny van Duijn-Bakker, et al.AIDS (London, England)|August 13, 2002
A delay in CD4 cell response after initiation of highly active antiretroviral therapy is associated with the presence of anti-cytomegalovirus but not with anti-herpes simplex virus antibodiesValère J Goossens, Gerrit Schreij, Siebe van der Geest, et al.Pageof 10